By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
The Life Science Nation (LSN) team is preparing for next week’s RESI Europe conference in Barcelona, where life science and healthcare innovators will connect with a global network of investors. With a curated agenda featuring six panels, attendees will gain key insights into emerging investment trends and strategies shaping the industry.
This year’s panels will cover Medical Devices, Digital Health, Corporate VC, Cross-Border Investments, Seed Funds, and Therapeutics Innovations. LSN has assembled a distinguished lineup of panelists representing diverse investment groups, from corporate venture capitalists to early-stage investors and sector specialists. These experts will share their approaches to evaluating startups, their perspectives on the evolving investment landscape, and their insights into fostering successful partnerships. As a truly international event, RESI Europe will bring together investors from across the globe, creating opportunities for cross-border collaboration and meaningful networking.
RESI panels are designed to facilitate constructive dialogue between investors and fundraising CEOs. Attendees will receive tactical advice on capital raising and partnership development, helping them refine their strategies and accelerate their fundraising efforts. These must-attend discussions offer founders and executives direct access to investors, providing an invaluable platform to expand their networks and gain actionable insights.
Join the panelists below at RESI Europe and take the next step in your fundraising journey.
 Carla Benichou Senior Investment Analyst RV Invest GmbH |
 Jorge Blasco Venture Partner (Spain) Lumo Labs |
 Nils Bottler Principal (Berlin) Angelini Ventures |
 Matthieu Coutet Partner, Biovelocita Strategy Sofinnova Partners |
 Geoffrey D’hondt Investment Director Heran Partners |
 Jordi Ferrer Healthcare Investment Director Ship2B Ventures |
 Lina Gaydarova Investment Manager Novaterra |
 Simon Hua Chairman BioMetas |
 Santiago Lozano Healthtech Funds Director Clave Capital |
 Jim McGough Managing Partner Mid Atlantic Bio Angels |
 Erki Mölder Managing Partner Verge Health Tech Fund |
 Daniel O’Mahony Partner Seroba Life Sciences |
 Luis Pareras Managing Partner Invivo Partners |
 Sanchita Pasi Investor EQT Life Sciences |
 William Pay Venture Partner Winhealth Pharma |
 Laura Rodriguez Partner Invivo Partners |
 Artemy Shumskiy Senior Associate LongeVC |
 Florence Thueux President & CEO M2Care |
 Louise Warme Head of We Venture Capital We Venture Capital |
||
Next Phase Newsletter 
Leave a comment